Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Barbosa

Showing results (461-470 of 465) with videos related to

Pageof 47
Sort By:
You have reached the last page of results.This site can display upto 465 results.
Clinical Immunology (Orlando, Fla.)|April 5, 2023
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patientsJordana Rodrigues Barbosa Fradico, Ana Carolina Campi-Azevedo, Elaine Speziali, et al.
Vaccine|September 4, 2023
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster doseMaria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, et al.
Frontiers in Immunology|August 9, 2020
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional StudyValéria Valim, Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamoto, et al.
Vaccines|November 26, 2025
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana StudyNésio Fernandes de Medeiros-Junior, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho, et al.
Viruses|January 1, 2020
Zika Virus Surveillance at the Human-Animal Interface in West-Central Brazil, 2017-2018Alex Pauvolid-Corrêa, Helver Gonçalves Dias, Laura Marina Siqueira Maia, et al.
Pageof 47

Showing results (461-470 of 465) with videos related to

Sort By:
Pageof 47
You have reached the last page of results.This site can display upto 465 results.
Clinical Immunology (Orlando, Fla.)|April 5, 2023
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patientsJordana Rodrigues Barbosa Fradico, Ana Carolina Campi-Azevedo, Elaine Speziali, et al.
Vaccine|September 4, 2023
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster doseMaria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, et al.
Frontiers in Immunology|August 9, 2020
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional StudyValéria Valim, Ketty Lysie Libardi Lira Machado, Samira Tatiyama Miyamoto, et al.
Vaccines|November 26, 2025
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana StudyNésio Fernandes de Medeiros-Junior, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho, et al.
Viruses|January 1, 2020
Zika Virus Surveillance at the Human-Animal Interface in West-Central Brazil, 2017-2018Alex Pauvolid-Corrêa, Helver Gonçalves Dias, Laura Marina Siqueira Maia, et al.
Pageof 47